TD Capital Management’s GSK GSK Stock Holding History

TD Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.19K	Hold	80	–	–	﹤0.01%	553
2026 Q1	$4.42K	Hold	80	–	–	﹤0.01%	573
2025 Q4	$3.92K	Hold	80	–	–	﹤0.01%	547
2025 Q3	$3.45K	Hold	80	–	–	﹤0.01%	526
2025 Q2	$3.07K	Hold	80	–	–	﹤0.01%	537
2025 Q1	$3.1K	Hold	80	–	–	﹤0.01%	427
2024 Q4	$2.71K	Hold	80	–	–	﹤0.01%	414
2024 Q3	$3.27K	Hold	80	–	–	﹤0.01%	375
2024 Q2	$3.08K	Hold	80	–	–	﹤0.01%	345
2024 Q1	$3.43K	Hold	80	–	–	﹤0.01%	353
2023 Q4	$2.96K	Hold	80	–	–	﹤0.01%	350
2023 Q3	$2.9K	Hold	80	–	–	﹤0.01%	349
2023 Q2	$2.85K	Hold	80	–	–	﹤0.01%	357
2023 Q1	$2.85K	Hold	80	–	–	﹤0.01%	352
2022 Q4	$2.81K	Hold	80	–	–	﹤0.01%	325
2022 Q3	$2K	Buy	+80	New	+$3.03K	﹤0.01%	322
2022 Q1	–	Sell	-80	Closed	-$4K	–	202
2021 Q4	$4K	Hold	80	–	–	﹤0.01%	320
2021 Q3	$4K	Hold	80	–	–	﹤0.01%	303
2021 Q2	$4K	Hold	80	–	–	﹤0.01%	292
2021 Q1	$4K	Hold	80	–	–	﹤0.01%	268
2020 Q4	$4K	Hold	80	–	–	﹤0.01%	234
2020 Q3	$4K	Hold	80	–	–	﹤0.01%	204
2020 Q2	$4K	Hold	80	–	–	﹤0.01%	204
2020 Q1	$4K	Hold	80	–	–	﹤0.01%	189
2019 Q4	$5K	Hold	80	–	–	﹤0.01%	209
2019 Q3	$4K	Hold	80	–	–	﹤0.01%	216
2019 Q2	$4K	Buy	+80	New	+$4.01K	﹤0.01%	208

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

TD Capital Management's GSK Position: Q2 2026 in Review

TD Capital Management held its GSK (GSK) position steady in Q2 2026 at 80 shares worth $4.19K. The position accounts for ﹤0.01% of the portfolio, ranked #553.

TD Capital Management first reported a position in GSK in Q2 2019 and has held it in 27 quarters since. The position peaked at $5K in Q4 2019. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

TD Capital Management held 80 shares of GSK worth $4.19K as of Q2 2026.
TD Capital Management left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of TD Capital Management's portfolio in Q2 2026, its #553 holding.
TD Capital Management first reported a position in GSK in Q2 2019 and has held it in 27 quarters since.
TD Capital Management's GSK position peaked at $5K in Q4 2019.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on TD Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.